Search and Select
We leverage the global network of the co-founders and investors to identify the most promising assets using their cumulative development and commercial expertise.
Efficiently Build the Portfolio
We utilize our deep experience in business development to ensure win-win licenses, partnerships or acquisitions that enable rapid creation of ACELYRIN’s therapeutics portfolio.
Maximize Program Potential
We design and implement development programs to reduce risks and accelerate timelines while maximizing the therapeutic and commercial potential.
Rapidly Assemble Teams and Resources
We can rapidly assemble teams and resources required for efficient prosecution of the development, regulatory, manufacturing and commercial processes.
Attract Capital Required for Success
We leverage our broad network of investment relationships to access the capital required for rapid growth and value creation.
We conduct a licensing and acquisition search process that is both directed and opportunistic.
Our directed search will be in the field of immunology, where we have deep expertise and resources needed to create value.
Opportunistically, we are open to platforms, programs and products when compelling science or data exist, particularly for clinical stage assets.